Response: Comment on "Significant decrease in plasma D-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism"

Clin Cardiol. 2022 Oct;45(10):976. doi: 10.1002/clc.23916. Epub 2022 Sep 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fibrin Fibrinogen Degradation Products
  • Humans
  • Mean Platelet Volume
  • Rosuvastatin Calcium / therapeutic use
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / drug therapy

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Rosuvastatin Calcium